Pravastatin

Therapy with lipid-altering agents should be only one component of multiple risk factor intervention in individuals at significantly increased risk for atherosclerotic vascular disease due to hypercholesterolemia. Drug therapy is indicated…

Prescribing label

Selected manufacturer label information, organised into consistent sections by Sofidex. This source is written for healthcare professionals; ask your pharmacist to explain instructions that are unclear. Read the full label at DailyMed ↗

Drug facts

Used for: To reduce the risk of myocardial infarction, myocardial revascularization procedures, and cardiovascular mortality in adults with elevated low-density lipoprotein cholesterol (LDL-C) without clinically evident coronary heart disease (CHD).
To reduce the risk of coronary death, myocardial infarction, myocardial revascularization procedures, stroke or transient ischemic attack, and slow the progression of coronary atherosclerosis in adults with clinically evident CHD.
As an adjunct to diet to reduce LDL-C in adults with primary hyperlipidemia.
Do not take if: Acute liver failure or decompensated cirrhosis.
Hypersensitivity to any pravastatin or any excipients in pravastatin sodium tablets.

What it is used for

Pravastatin sodium tablets are indicated:

To reduce the risk of myocardial infarction, myocardial revascularization procedures, and cardiovascular mortality in adults with elevated low-density lipoprotein cholesterol (LDL-C) without clinically evident coronary heart disease (CHD).
To reduce the risk of coronary death, myocardial infarction, myocardial revascularization procedures, stroke or transient ischemic attack, and slow the progression of coronary atherosclerosis in adults with clinically evident CHD.
As an adjunct to diet to reduce LDL-C in adults with primary hyperlipidemia.
As an adjunct to diet to reduce LDL-C in pediatric patients ages 8 years and older with heterozygous familial hypercholesterolemia (HeFH).
As an adjunct to diet for the treatment of adults with:
- Primary dysbetalipoproteinemia.
- Hypertriglyceridemia.

Side effects, and when to stop

The following important adverse reactions are described below and elsewhere in the labeling:

Myopathy and Rhabdomyolysis
Immune-Mediated Necrotizing Myopathy
Hepatic Dysfunction
Increases in HbA1c and Fasting Serum Glucose Levels

Who should not take it

Acute liver failure or decompensated cirrhosis.
Hypersensitivity to any pravastatin or any excipients in pravastatin sodium tablets.

Cite this page

NLM: sofidex [Internet]. Daloreum; c2026. Pravastatin; [reviewed 2026 Aug 3; cited 2026 Nov 10]. Available from: https://sofidex.com/patients/medicines/pravastatin
APA 7th: sofidex. (2026, August 3). Pravastatin. Daloreum. Retrieved November 10, 2026, from https://sofidex.com/patients/medicines/pravastatin
AMA 11th: Pravastatin. sofidex. Reviewed August 3, 2026. Accessed November 10, 2026. https://sofidex.com/patients/medicines/pravastatin

The cited date is today’s, because a citation records when you read the page. The reviewed date is when a clinician last checked it.